{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T02:23:56Z","timestamp":1720319036693},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.parkreldis.2016.07.020","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T18:58:38Z","timestamp":1470250718000},"page":"153-155","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Facial movement disorder and dopamine imaging in a patient with amphetamine abuse"],"prefix":"10.1016","volume":"31","author":[{"given":"Joan Philipp","family":"Michelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janis Rebecca","family":"Bedarf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Bundschuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian C.","family":"Gaertner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Paus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2016.07.020_bib1","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/mds.22599","article-title":"Substance abuse and movement disorders","volume":"25","author":"Brust","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.07.020_bib2","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","article-title":"Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428","volume":"18","author":"McCann","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2016.07.020_bib3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.parkreldis.2016.07.020_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-001-0930-0","article-title":"Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study\u2013preliminary report","volume":"159","author":"Reneman","year":"2002","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.parkreldis.2016.07.020_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nucmedbio.2005.12.007","article-title":"Repeated administration of D-amphetamine induces loss of [123I]FP-CIT binding to striatal dopamine transporters in rat brain: a validation study","volume":"33","author":"Booij","year":"2006","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.parkreldis.2016.07.020_bib6","series-title":"International Review of Neurobiology, The Neuropsychiatric Complications of Stimulant Abuse","first-page":"131","article-title":"Neurologic complications of psychomotor stimulant abuse","author":"Sanchez-Ramos","year":"2015"},{"key":"10.1016\/j.parkreldis.2016.07.020_bib7","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001","article-title":"Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence","volume":"21","author":"Volkow","year":"2001","journal-title":"J. Neurosci."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201630284X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201630284X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T03:58:14Z","timestamp":1568260694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380201630284X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":7,"alternative-id":["S135380201630284X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.07.020","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Facial movement disorder and dopamine imaging in a patient with amphetamine abuse","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}